(Q34056476)

30 July 2017

1 reference

title

Cutaneous viral infections in HIV-infected individuals (English)

1 reference

30 July 2017

Yen-Moore A

1

1 reference

30 July 2017

Vander Straten M

2

1 reference

30 July 2017

Carrasco D

3

1 reference

30 July 2017

Evans TY

4

1 reference

30 July 2017

Tyring SK

5

1 reference

30 July 2017

publication date

1 July 2000

1 reference

30 July 2017

published in

Clinics in Dermatology

1 reference

30 July 2017

volume

18

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

423-432

1 reference

Clinical and serologic features of herpes simplex virus infection in patients with AIDS

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Infections with herpes simplex viruses (2).

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Severe, progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Disseminated herpes simplex type 2 and systemic Candida infection in a patient with previous asymptomatic human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Human immunodeficiency virus infection among men with sexually transmitted diseases. Experience from a center in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

The impact of active herpes simplex virus infection on human immunodeficiency virus load

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Herpes zoster: a possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Varicella-zoster virus infections in children infected with human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Chronic varicella zoster infection in acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Disseminated herpes zoster in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS).

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Oral hairy leukoplakia: observations in 95 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Fatal cytomegalic inclusion disease. Associated skin manifestations in a renal transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Epidermolysis in a case of severe cytomegalovirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Acyclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Combination therapy in primary HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Safety of famciclovir in patients with herpes zoster and genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Epidemiological Synergy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Acyclovir-resistant herpes in AIDS treated with foscarnet.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Treatment of oral 'hairy' leukoplakia in AIDS patients with vitamin A acid (topically) or acyclovir (systemically)

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Prevalence, diagnosis and treatment of lower genital neoplasia in women with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Human papillomavirus infection in human immunodeficiency virus-seropositive women

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Human papillomavirus is associated with the frequent detection of warty and basaloid high-grade neoplasia of the vulva and cervical neoplasia among immunocompromised women

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Incidence of venereal warts in human immunodeficiency virus-infected and uninfected women

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

The correlation between HIV seropositivity, cervical dysplasia, and HPV subtypes 6/11, 16/18, 31/33/35

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Viral co-infections in human papillomavirus-associated anogenital lesions according to the serostatus for the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Cervical dysplasia in HIV-seropositive women: role of human papillomavirus infection and immune status

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Management of the female HIV-infected patient

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

High Frequency of Latent and Clinical Human Papillomavirus Cervical Infections in Immunocompromised Human Immunodeficiency Virus-Infected Women

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Systemic immunosuppression by HIV infection influences HPV transcription and thus local immune responses in condyloma acuminatum

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Langerhans' cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Generation of infectious retrovirus aerosol through medical laser irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Infectious papillomavirus in the vapor of warts treated with carbon dioxide laser or electrocoagulation: detection and protection

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Interferons alpha, beta and gamma therapy of anogenital human papillomavirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Treatment with interferon for genital HPV in HIV-positive and HIV-negative women

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Immunomodulatory therapy in the management of viral infections in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC).

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Bacterial, viral, fungal, and parasitic infections in HIV disease and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900137-6

7 January 2021

Quercetin and kaempherol: an argument against the use of podophyllin?

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1136/STI.71.2.92

Identifiers

DOI

10.1016/S0738-081X(99)00137-6

1 reference

release_m45pljvi75hwbnghwfvmoxzggi

30 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/m45pljvi75hwbnghwfvmoxzggi

24 November 2022

mapped directly with Wikidata item

1 reference